XML 45 R32.htm IDEA: XBRL DOCUMENT
v3.22.4

Equity-Based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract] |
Schedule of Remaining Unrecognized Compensation Expense | The following table shows the remaining unrecognized compensation expense on a pre-tax basis for all types of unvested equity awards outstanding as of December 31, 2022. This table does not include an estimate for future grants that may be issued.
2023 | $ | 11,273 |
2024 | 7,781 |
2025 | 4,117 |
2026 | 408 |
| $ | 23,579 |
Schedule of Weighted-Average Assumptions Used to Calculate Fair Value of Stock Settled Stock Appreciation Rights | Following is a table that includes the weighted-average assumptions that the Company used to calculate fair value of stock-settled stock appreciation rights that were granted during the periods indicated.
| Year Ended
| 2022 |  | 2021 |  | 2020
Expected volatility (1) | N/A |  | 43.28 | % |  | 35.23 | %
Risk-free interest rate (2) | N/A |  | 0.33 | % |  | 1.66 | %
Expected life (3) | N/A |  | 3.5 yrs |  | 3.5 yrs.
Expected dividend yield (4) | N/A |  | 0.00 | % |  | 0.00 | %
Weighted-average exercise price (5) | N/A |  | $ | 85.19 |  |  | $ | 63.02 |
(1)The Company utilizes historical volatility of the trading price of its common stock. (2)Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award. (3)Depending upon the terms of the award, one of two methods will be used to calculate expected life: (i)a weighted-average that includes historical settlement data of the Company’s equity awards and a hypothetical holding period, or (ii) the simplified method. (4)The Company historically has not paid and currently has no plan to pay dividends. (5)Exercise price is the closing price of the Company's common stock on the date of grant.
Schedule of Stock-Settled Appreciation Right Activity | A summary of the Company’s stock-settled stock appreciation right activity is as follows:
| Shares |  | Weighted-average exercise price |  | Weighted-average remaining contractual term |  | Aggregate intrinsic value*
Outstanding at January 1, 2022 | 150 |  |  | $ | 82.22 |  |  | 2.3 |  | $ | 3,596 |
Granted | — |  |  | — |  |  |  |  |
Exercised | (2) |  |  | 63.02 |  |  |  |  |
Forfeited | — |  |  | — |  |  |  |  |
Expired | (1) |  |  | 116.06 |  |  |  |  |
Outstanding at December 31, 2022 | 147 |  |  | $ | 82.16 |  |  | 1.3 |  | $ | — |
Exercisable at December 31, 2022 | 72 |  |  | $ | 90.63 |  |  | 1.1 |  | $ | — |
* Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company’s common stock on the last trading day of the period) and the exercise price of awards that were in-the-money. The closing price of the Company’s common stock at December 31, 2022 and January 1, 2022 was $53.20 and $101.20, respectively.
Schedule of Stock-Settled Restricted Stock Unit Activity | A summary of the Company’s stock-settled restricted stock unit activity is as follows:
| Shares |  | Weighted-average grant date fair value
Outstanding at January 1, 2022 | 366 |  | $ | 80.87 |
Granted | 170 |  | 91.67 |
Vested | (142) |  | 81.11 |
Forfeited | (9) |  | 83.11 |
Outstanding at December 31, 2022 | 385 |  | $ | 85.50 |
Schedule of Cash-Settled Restricted Stock Unit Activity | A summary of the Company’s cash-settled restricted stock unit activity is as follows:
| Shares |  | Weighted-average grant date fair value
Nonvested at January 1,2022 | 12 |  | $ | 78.66 |
Granted | 6 |  | 91.53 |
Vested | (3) |  | 79.22 |
Forfeited | (3) |  | 79.67 |
Nonvested at December 31,2022 | 12 |  | $ | 84.72 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration